MedPath

A Study in Healthy People to Compare Two Different Sifrol® Tablets

Phase 1
Completed
Conditions
Healthy
Registration Number
NCT06457204
Lead Sponsor
Boehringer Ingelheim
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
All
Target Recruitment
Not specified
Inclusion Criteria

Inclusion Criteria:<br><br> 1. Healthy male or female subjects according to the assessment of the investigator, as<br> based on a complete medical histo1y including a physical examination, vital signs<br> (blood pressure (BP), pulse rate (PR)), 12-lead electrocardiogram (ECG), and<br> clinical laboratory tests<br><br> 2. Age of 18 to 55 years (inclusive)<br><br> 3. Body mass index (BMI) of 18.5 to 29.9 kg/m² (inclusive)<br><br> 4. Signed and dated written informed consent in accordance with ICH-GCP and local<br> legislation prior to admission to the trial Further inclusion criteria apply.<br><br>Exclusion Criteria:<br><br> 1. Any finding in the medical examination (including BP, PR or ECG) deviating from<br> normal and assessed as clinically relevant by the investigator<br><br> 2. Repeated measurement of systolic blood pressure outside the range of 90 to 140 mmHg,<br> diastolic blood pressure outside the range of 50 to 90 mmHg, or pulse rate outside<br> the range of 45 to 90 beats per minute (bpm)<br><br> 3. Any laboratory value outside the reference range that the investigator considers to<br> be of clinical relevance<br><br> 4. Any evidence of a concomitant disease assessed as clinically relevant by the<br> investigator Further exclusion criteria apply.

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 to the last quantifiable data point (AUC0-tz);Maximum measured concentration of the analyte in plasma (Cmax)
Secondary Outcome Measures
NameTimeMethod
Area under the concentration-time curve of the analyte in plasma over the time interval from 0 extrapolated to infinity (AUC0-8)
© Copyright 2025. All Rights Reserved by MedPath